Literature DB >> 23091119

Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis.

Ajay Gupta1, J Levi Chazen, Maya Hartman, Diana Delgado, Nikesh Anumula, Huibo Shao, Madhu Mazumdar, Alan Z Segal, Hooman Kamel, Dana Leifer, Pina C Sanelli.   

Abstract

BACKGROUND AND
PURPOSE: Impairments in cerebrovascular reserve (CVR) have been variably associated with increased risk of ischemic events and may stratify stroke risk in patients with high-grade internal carotid artery stenosis or occlusion. The purpose of this study is to perform a systematic review and meta-analysis to summarize the association of CVR impairment and stroke risk.
METHODS: We performed a literature search evaluating the association of impairments in CVR with future stroke or transient ischemic attack in patients with high-grade internal carotid artery stenosis or occlusion. We included studies with a minimum of 1-year patient follow-up with baseline CVR measures performed by any modality and primary outcome measures of stroke and/or transient ischemic attack. A meta-analysis with assessment of study heterogeneity and publication bias was performed. Results were presented in a forest plot and summarized using a random-effects model.
RESULTS: Thirteen studies met the inclusion criteria, representing a total of 1061 independent CVR tests in 991 unique patients with a mean follow-up of 32.7 months. We found a significant positive relationship between impairment of CVR and development of stroke with a pooled random effects OR of 3.86 (95% CI, 1.99-7.48). Subset analysis showed that this association between CVR impairment and future risk of stroke/transient ischemic attack remained significant regardless of ischemic outcome measure, symptomatic or asymptomatic disease, stenosis or occlusion, or CVR testing method.
CONCLUSIONS: CVR impairment is strongly associated with increased risk of ischemic events in carotid stenosis or occlusion and may be useful for stroke risk stratification.

Entities:  

Mesh:

Year:  2012        PMID: 23091119      PMCID: PMC3500140          DOI: 10.1161/STROKEAHA.112.663716

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  22 in total

1.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

2.  Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients?

Authors:  A Y Gur; I Bova; N M Bornstein
Journal:  Stroke       Date:  1996-12       Impact factor: 7.914

3.  Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis.

Authors:  M Silvestrini; F Vernieri; P Pasqualetti; M Matteis; F Passarelli; E Troisi; C Caltagirone
Journal:  JAMA       Date:  2000-04-26       Impact factor: 56.272

4.  Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion.

Authors:  H Markus; M Cullinane
Journal:  Brain       Date:  2001-03       Impact factor: 13.501

5.  Course of carotid artery occlusions with impaired cerebrovascular reactivity.

Authors:  B Kleiser; B Widder
Journal:  Stroke       Date:  1992-02       Impact factor: 7.914

6.  Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Authors:  A Halliday; A Mansfield; J Marro; C Peto; R Peto; J Potter; D Thomas
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

7.  Population-based study of symptomatic internal carotid artery occlusion: incidence and long-term follow-up.

Authors:  Matthew L Flaherty; Kelly D Flemming; Robyn McClelland; Neal W Jorgensen; Robert D Brown
Journal:  Stroke       Date:  2004-07-01       Impact factor: 7.914

8.  Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease.

Authors:  M W Webster; M S Makaroun; D L Steed; H A Smith; D W Johnson; H Yonas
Journal:  J Vasc Surg       Date:  1995-02       Impact factor: 4.268

9.  Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.

Authors:  H J M Barnett; D W Taylor; R B Haynes; D L Sackett; S J Peerless; G G Ferguson; A J Fox; R N Rankin; V C Hachinski; D O Wiebers; M Eliasziw
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

10.  Use of cerebrovascular reactivity in patients with symptomatic major cerebral artery occlusion to predict 5-year outcome: comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography.

Authors:  Kuniaki Ogasawara; Akira Ogawa; Kazunori Terasaki; Hiroaki Shimizu; Teiji Tominaga; Takashi Yoshimoto
Journal:  J Cereb Blood Flow Metab       Date:  2002-09       Impact factor: 6.200

View more
  99 in total

1.  Acute Preoperative Infarcts and Poor Cerebrovascular Reserve Are Independent Risk Factors for Severe Ischemic Complications following Direct Extracranial-Intracranial Bypass for Moyamoya Disease.

Authors:  Michael U Antonucci; Terrence C Burns; T Michael Pulling; Jarrett Rosenberg; Michael P Marks; Gary K Steinberg; Greg Zaharchuk
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-12       Impact factor: 3.825

Review 2.  Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Authors:  Chirantan Banerjee; Marc I Chimowitz
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2 ) using quantitative susceptibility mapping (QSM).

Authors:  Jingwei Zhang; Tian Liu; Ajay Gupta; Pascal Spincemaille; Thanh D Nguyen; Yi Wang
Journal:  Magn Reson Med       Date:  2014-09-26       Impact factor: 4.668

Review 4.  Sex differences in stroke: the contribution of coagulation.

Authors:  Meaghan Roy-O'Reilly; Louise D McCullough
Journal:  Exp Neurol       Date:  2014-02-19       Impact factor: 5.330

5.  Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.

Authors:  Yosuke Ishii; Thoralf Thamm; Jia Guo; Mohammad Mehdi Khalighi; Mirwais Wardak; Dawn Holley; Harsh Gandhi; Jun Hyung Park; Bin Shen; Gary K Steinberg; Frederick T Chin; Greg Zaharchuk; Audrey Peiwen Fan
Journal:  J Magn Reson Imaging       Date:  2019-05-01       Impact factor: 4.813

6.  Imaging of cerebrovascular reserve and oxygenation in Moyamoya disease.

Authors:  Wendy W Ni; Thomas Christen; Jarrett Rosenberg; Zungho Zun; Michael E Moseley; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 7.  Comparison of cerebral blood flow measurement with [15O]-water positron emission tomography and arterial spin labeling magnetic resonance imaging: A systematic review.

Authors:  Audrey P Fan; Hesamoddin Jahanian; Samantha J Holdsworth; Greg Zaharchuk
Journal:  J Cereb Blood Flow Metab       Date:  2016-03-04       Impact factor: 6.200

Review 8.  Global cerebral ischemia due to circulatory arrest: insights into cellular pathophysiology and diagnostic modalities.

Authors:  Santosh K Sanganalmath; Purva Gopal; John R Parker; Richard K Downs; Joseph C Parker; Buddhadeb Dawn
Journal:  Mol Cell Biochem       Date:  2016-11-28       Impact factor: 3.396

9.  The Effects of Acetazolamide on the Evaluation of Cerebral Hemodynamics and Functional Connectivity Using Blood Oxygen Level-Dependent MR Imaging in Patients with Chronic Steno-Occlusive Disease of the Anterior Circulation.

Authors:  J Wu; S Dehkharghani; F Nahab; J Allen; D Qiu
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-06       Impact factor: 3.825

10.  Comparison of Blood Oxygenation Level-Dependent fMRI and Provocative DSC Perfusion MR Imaging for Monitoring Cerebrovascular Reserve in Intracranial Chronic Cerebrovascular Disease.

Authors:  K R Thulborn; I C Atkinson; A Alexander; M Singal; S Amin-Hanjani; X Du; A Alaraj; F T Charbel
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.